3-Methoxyamphetamine

Category

3-Methoxyamphetamine




Useful info

3-Methoxyamphetamine Brand names, 3-Methoxyamphetamine Analogs

3-Methoxyamphetamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

    • 3-Methoxyamphetamine Chemical_Formula

    C9H13N

    3-Methoxyamphetamine RX_link

    http://www.rxlist.com/cgi/generic3/adderallxr.htm

    3-Methoxyamphetamine fda sheet

    3-Methoxyamphetamine msds (material safety sheet)

    3-Methoxyamphetamine Synthesis Reference

    U. S. Pat. 1,879,003, (1932)

    3-Methoxyamphetamine Molecular Weight

    135.206 g/mol

    3-Methoxyamphetamine Melting Point

    Volatizes slowly at room temperature

    3-Methoxyamphetamine H2O Solubility

    Slightly

    3-Methoxyamphetamine State

    Solid

    3-Methoxyamphetamine LogP

    1.799

    3-Methoxyamphetamine Dosage Forms

    Capsules

    3-Methoxyamphetamine Indication

    For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

    3-Methoxyamphetamine Pharmacology

    Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

    3-Methoxyamphetamine Absorption

    It forms easily absorbed molecules that are highly lipid soluble

    3-Methoxyamphetamine Toxicity

    LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

    3-Methoxyamphetamine Patient Information

    Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

    3-Methoxyamphetamine Organisms Affected

    Humans and other mammals